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Abstract: Veronica genus (Plantaginaceae) is broadly distributed in different habitats. In this study, the inhibitory activity of free soluble 
and conjugated phenolic extracts of Veronica persica on key enzymes associated to type 2 diabetes (α-glucosidase and α-amylase) and hyper-
tension (angiotensin I converting enzyme, ACE) was assessed, as well as their antioxidant power. Our results showed that both the extracts 
inhibited α-amylase, α-glucosidase and ACE in a dose-dependent manner. In particular, free phenolic extract significantly (P < 0.05) inhibited 
α-glucosidase (IC50 532.97 µg/mL), whereas conjugated phenolic extract significantly (P < 0.05) inhibited α-amylase (IC50 489.73 µg/mL) and 
ACE (290.06 µg/mL). The enzyme inhibitory activities of the extracts were not associated with their phenolic content. Anyway, the inhibition 
of α-amylase, α-glucosidase and ACE, along with the antioxidant capacity of the phenolic-rich extracts, could represent a putative mechanism 
through which V. persica exerts its antidiabetes and antihypertension effects.
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Introduction
Type-2 diabetes mellitus accounts for over 90% of 
all instances of diabetes, both in developed and deve-
loping countries. About 382 million people are consi-
dered to be living with diabetes all over the world, with 
an impressive prediction of 471 million people with the 
disease by the year 2035 (1). Postprandial hyperglyce-
mia has been implicated in the development of insulin 
resistance (2), being one of the first markers of glucose 
homeostasis deregulation (3). In addition, hypertension, 
cardiovascular disease and diabetic neuropathy are as-
sociate with this status (4, 5). A therapeutic approach in 
the prevention/control of hyperglycemia is through the 
delay of glucose absorption by inhibiting important en-
zymes involved in carbohydrate hydrolysis (α-amylase) 
and glucose release from disaccharide (α-glucosidase). 
However, some drugs widely used (acarbose and migli-
tol) to reduce blood glucose level are not exempt from 
a number of pharmacological side effects (6, 7). There-
fore, there exists a continued necessity for alternative, 
natural α-amylase and α-glucosidase inhibitors with 
high specificity and less adverse effects.
As previously introduced, long term diabetes is ge-
nerally associated with hypertension (8), which, in turn, 
represents risk factors for cardiovascular diseases and 
is chronic renal failure (8, 9). Angiotensin-I converting 
enzyme (ACE) is a zinc metallopeptidase that converts 
angiotensin-I to angiotensin-II, a strong vasoconstric-
tor, and breaks down bradykinin, a vasodilator (10). 
Inhibition of ACE is considered an effective therapeutic 
approach in the control of hypertension both in diabetic 
and nondiabetic patients (10). In this context, dietary 
phytochemicals, particularly phenolics, may play a pro-
tective role both in diabetes and hypertension (11, 12).
Nonetheless, chronic hyperglycemia in diabetes 
triggers oxidative stress at tissue and organ levels (6), 
which could be controlled by antioxidant agents. Inte-
rest on natural, dietary antioxidants is currently growing 
(13-16). Phenolic compounds represent a large group 
of bioactive phytochemicals which occur in almost all 
medicinal and food plants, because of their very high 
ecological relevance in plant organisms (17). Their in 
vitro antioxidant power, as well as other pharmacologi-
cal activities, have been extensively demonstrated since 
years (18).
The genus Veronica is the most important genus 
belonging to the Plantaginaceae family, with about 
500 species widely diffused in boreal hemisphere and 
present in many parts of the austral hemisphere. This 
is indicative of high ecological adaptability and genetic 
plasticity, with species growing in humid to dry envi-
ronments, from the sea level to alpine biotopes (19). In 
traditional medicine, Veronica species are used as diure-
tic, wound healing, antirheumatic and anticancer agents 
(20-22). In addition, stems and leaves of some Veronica 
species are edible, either raw or cooked (23). Despite 
the use of Veronica species in traditional healing sys-
tems is extensively reported, there exists a paucity of 
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information documenting their pharmacological acti-
vities and mechanisms involved in the observed health 
benefits. Veronica persica (common names: birdeye 
speedwell, common field-speedwell, Persian speedwell, 
large field speedwell, bird's-eye or winter speedwell‎‎) is 
a flowering plant native to Eurasia. To the best of our 
knowledge, no information is available on the possible 
mechanism(s) of action of V. persica extracts in decrea-
sing blood glycemia and management of hypertension. 
Hence, the present study aims primarily at investigating 
the inhibitory activity of phenolic-rich extracts of V. 
persica on key enzymes involved in diabetes and hyper-
tension, i.e. α-amylase, α-glucosidase and ACE.
Materials and Methods
Plant material
Aerial parts (stems, leaves and flowers) of Veronica 
persica were collected at flowering stage, in November 
2014, from wild plants in the mountains of Meymand, 
Firuzabad County, Fars Province, Iran. The plant was 
taxonomically identified by a botanist and a specimen 
was deposited at the Herbarium of Pharmacognosy, De-
partment of the Faculty of Pharmacy affiliated to Zabol 
University of Medical Sciences of Iran. The collected 
plant materials were dried in the shade, powdered and 
stored at 10 °C until required for analysis.
Free soluble phenolic extraction
Free phenolic extraction was performed according to 
a slight modified method described by Chu et al. (24). 
Twenty grams of the powdered sample were extracted 
with 80% acetone (1:5, w/v) and filtered (filter paper 
Whatman No. 2) under vacuum. The filtrate was then 
evaporated by a rotary evaporator under vacuum at 
40 °C until about 90% of the filtrate had been evapo-
rated and then lyophilized to obtain a dry extract. The 
residues were kept for conjugated phenolic extraction, 
while extract was kept at -4 °C for next analyses.
Conjugated phenolic extraction
The residue from free extraction was flushed with 
nitrogen and hydrolyzed with about 30 mL of 4 M 
NaOH solution at room temperature (24 ± 1°C) for 1 
h with shaking. Afterward, the pH of the mixture was 
adjusted to pH 2 with concentrated HCl and the conju-
gated phytochemicals were extracted with ethylacetate. 
The ethylacetate fractions were then evaporated to dry-
ness at 40°C.
Total phenol content determination 
The total phenol content was assayed according to 
the method described by Singleton et al. (25). Briefly, 
appropriate dilutions of the extracts were oxidized with 
3 mL 10% Folin-Ciocalteau’s reagent (v/v) and neu-
tralized by 2 mL of 8% sodium carbonate. The reac-
tion mixture was incubated for 45 min at 45°C and the 
absorbance was measured by using spectrophotometer-
UV (Shimadzu A160) at 765 nm (A765). The total phenol 
content was calculated as gallic acid equivalent.
Reducing power determination
The reducing power of the extracts was determined 
by evaluating the ability of the extract to reduce FeCl3 
solution by method of Oyaizu (26). A 3 mL aliquot was 
mixed with 3 mL of 200 mM sodium phosphate buffer 
(pH 6.5) and 3 mL of 1% potassium ferricyanide. The 
mixture was incubated at 45 °C for 25 min and then 
was added 3 mL of 10% trichloroacetic acid. This mix-
ture was centrifuged at 2600 rpm for 15 min. Five mL 
of the supernatant were mixed with an equal volume of 
distilled water and 1 mL of 0.1% ferric chloride. The 
absorbance was measured at 700 nm (A700) in the spec-
trophotometer-UV (Shimadzu A160) and ferric redu-
cing power was subsequently calculated using ascorbic 
acid as standard.
Total antioxidant capacity
The total antioxidant capacity was by 2,2-azinobis(3-
ethylbenzothiazoline-6-sulfonate radical (ABTS) 
scavenging ability of the extracts according to the 
method described by Sharifi Rad et al. (27). The ABTS 
was generated by reacting ABTS aqueous solution (7 
mM) with K2S2O8 (2.45 mM, final concentration), in the 
dark, for 14 h and adjusting the absorbance at 734 nm 
to 0.700 with ethanol. Then, 0.2 mL of appropriate dilu-
tion of the extracts were added to 2.0 mL ABTS solution 
and the absorbance was measured at 734 nm in the spec-
trophotometer-UV (Shimadzu A160) after 15 min. The 
trolox equivalent antioxidant capacity (TEAC) was sub-
sequently calculated using trolox (a synthetic antioxi-
dant) as the standard.
α-Amylase inhibitory activity
Phenolic extract dilutions (0-150 µL) and 500 µL 
of 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 
M NaCl) containing porcine pancreatic α-amylase (EC 
3.2.1.1) (0.5 mg/mL) were incubated at 25 °C for 15 
min. Then, 500 µL of 1% starch solution in 0.02 M 
sodium phosphate buffer (pH 6.9 with 0.006 M NaCl) 
were added to each tube. The reaction mixture was in-
cubated at 25 °C for 15 min and stopped with 1.0 mL 
of dinitrosalicylic acid colour reagent. Afterwards, the 
mixture was incubated in a boiling distilled water bath 
for 5 min, and cooled to room temperature (24±1°C). 
The reaction mixture was then diluted by adding 10 
mL of distilled water, and absorbance measured at 540 
nm (A540) by using spectrophotometer-UV (Shimadzu 
A160). The α-amylase inhibitory activity was expressed 
as % inhibition (28).
α-Glucosidase inhibitory activity
Phenolic extracts dilutions (0-150 µL) and 100 µL of 
α-glucosidase (EC 3.2.1.20) solution (1.0 U/mL) in 0.1 
M phosphate buffer (pH 6.9) were incubated at 25°C 
for 15 min. Then, 50 µL of 5 mM p-nitrophenyl-α-D-
glucopyranoside solution in 0.1 M phosphate buffer 
(pH 6.9) were added. Before reading the absorbance at 
405 nm (A405) in the spectrophotometer-UV (Shimadzu 
A160), the mixtures were incubated at 25 °C for 5 min. 
The α-glucosidase inhibitory activity was expressed as 
% inhibition (29).
Angiotensin I converting enzyme inhibition
Angiotensin I converting enzyme (ACE) inhibi-
tory activity was carried out using a slightly modified 
method of Cushman and Cheung (30). The phenolic ex-
tract dilutions (0-50 µL) and 50 µL ACE (EC 3.4.15.1) 
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inhibit the α-amylase correlated with their total phenol 
content (Table 2). Therefore, inhibition of α-amylase 
activity, here in vitro demonstrated, could be one of the 
putative mechanisms supporting the efficacy of plant 
(including V. persica) extracts in the control of diabetes.
The inhibition of V. persica phenolic-rich extracts 
on α-glucosidase is shown in Figure 2. Both extracts 
dose-dependently inhibited α-glucosidase activity (P < 
0.05), though with a different tend (Figure 2). Inhibition 
by free phenolic extract (IC50 532.97 µg/mL) was more 
active than the bound phenolic extract (IC50 825.78 µg/
mL) (Table 1).
Polyphenols have been shown to inhibit α-amylase 
and α-glucosidase, which may postpone rapid absorp-
tion of glucose (42). However, in our experimental 
conditions, free phenolic extract exhibited a higher in-
solution (4 mU/mL) were incubated at 37°C for 15 min. 
The enzymatic reaction was initiated by adding 150 µL 
of 8.33 mM of the substrate Bz–Gly–His–Leu in 125 
mM Tris-HCl buffer (pH 8.3) to the mixture. The reac-
tion was arrested by adding 250 µL of 1 M HCl, after 
incubation for 30 min at 35°C. The Gly–His bond was 
then cleaved and the Bz–Gly produced by the reaction 
was extracted with 1.5 mL ethylacetate. Afterwards, the 
mixture was centrifuged to separate the ethylacetate 
layer; 1 mL of the ethylacetate layer was transferred to 
a clean test tube and evaporated. The residue was redis-
solved in distilled water and its absorbance was mea-
sured at 228 nm (A228) by using spectrophotometer-UV 
(Shimadzu A160). The ACE inhibitory activities were 
expressed as % inhibition.
IC50 determination for α-amylase, α-glucosidase and 
ACE
IC50 is defined as the concentration of phenolic-rich 
extracts (in our experiments) required inhibiting 50% 
of the enzyme activity. The IC50 was calculated by 
using the formula described by Sharifi-Rad et al. (31): 
EXP (LN (conc > 50%) - ((signal > 50%-50)/(signal > 
50%-signal < 50%)*LN (conc >50%/conc <50%))).
Data analysis
Statistical significance was determined by Student’s 
t-test and significance was accepted at P < 0.05. The 
results of triplicate tests were expressed as mean ± stan-
dard deviation (SD).
Results and Discussion
Inhibition of enzymes involved in the metabolism 
of carbohydrates, such as α-amylase and α-glucosidase, 
and angiotensin I convertion (ACE) is a key therapeu-
tic approach for decreasing postprandial hyperglycemia 
and hypertension (11, 32-35). 
The α-amylase inhibitory activity of V. persica phe-
nolic-rich extracts is reported in Figure 1. Both extracts 
dose-dependently inhibited the enzyme activity (P < 
0.05), even if the bound (conjugated) phenolic extract 
was more effective (IC50 489.73 µg/mL) than the free 
phenolic extract (IC50 742.76 µg/mL) (Figure 1, Table 
1). The inhibitory activity of the V. persica extracts on 
α-amylase activity was consistent with previous studies 
on phenolic extracts derived from other plants (36-41). 
The general trend of the extracts from V. persica to 
Figure 1. α-Amylase inhibitory activities of Veronica persica 



























Concentration of extract (µg/mL)
Free phenolic extract
Bound phenolic extract
V. persica extracts IC50 (µg/mL)
α-Amylase α-Glucosidase ACE
Free phenolics 742.76 532.97 383.90
Bound phenolics 489.73 825.78 290.06
Data represent mean (n=3; P < 0.05).
Table 1. IC50 of the Veronica persica phenolic-rich extracts on α -amilase, α -glucosidase and angiotensin I converting enzyme (ACE).
V. persica extracts TP (mg/100 g) RP (mmol AAE/100 g) TAC (mmol TEAC/100 g)
Free phenolics 78.45 ± 1.3 8.86 ± 0.5 9.49 ± 1.2
Bound phenolics 54.77 ± 5.2 7.85 ± 1.39 6.99 ± 3.6
Data represent mean ± standard deviation (n=3; P < 0.05). TP: total phenols; RP: teducing power; TAC: total antioxidant capacity; 
AAE: ascorbic acid equivalents; TEAC: trolox-equivalent antioxidant capacity.
Table 2. Total phenol content and antioxidant capacity of Veronica persica phenolic-rich extracts.
Figure 2. α-Glucosidase inhibitory activities of Veronica persica 
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hibitory activity on α-glucosidase in comparison with 
α-amylase: interestingly, the use of V. persica phenolic-
rich extracts could reveal an even better effect in dia-
bete control over the commercial antidiabetic drugs cur-
rently in use, which have a relatively low α-glucosidase 
inhibitory activity. 
Nevertheless, these findings are consistent with pre-
vious reports where phytochemicals showed higher 
α-glucosidase than α-amylase inhibition (34, 38, 39, 
43-45). This aspect would avoid side effects associated 
with some of the anti-diabetes drugs currently in use 
(acarbose and voglibose), which possess an excess of 
α-amylase inhibition (46). Therefore, plant phenolics 
with mild α-amylase and high α-glucosidase inhibitory 
activities have been proposed as acceptable alternative 
for clinician to the corresponding synthetic inhibitors 
(34).
Moreover, the antihypertensive potential of pheno-
lic extracts has also been investigated through the inhi-
bition of angiotensin I converting enzyme (ACE). As 
shown in Figure 3, both extracts exhibited a high ACE 
inhibitory activity, in a dose-dependent manner. In par-
ticular, the bound phenolic extract showed significantly 
higher (P < 0.05) inhibitory activity on the enzyme than 
the free phenolic extract. The IC50 values also confirmed 
these results, with bound phenolic extract significantly 
(P < 0.05) less active (IC50 290.06 µg/mL) than the free 
phenolic extract (IC50 383.90 µg/mL) (Table 1). Studies 
on the physical structure of human ACE have shown 
the presence of cysteine groups in the protein surface, 
which are available to form disulfide bridges (33). The-
refore, ACE inhibitory activity of V. persica extracts 
may be due to the interactions between V. persica (free 
and bound) phenolics and disulfide bridges (oxidized 
cysteines) on the macromolecule surface, thus causing 
structural and functonal changes in turn associated with 
enzyme inhibition (33).
Our results support the higher α-amylase and ACE 
inhibitory activities of the bound phenolic extract in 
comparison with the free phenolic extract. A main rea-
son may be related to the higher hydrophilicity of bound 
phenolics, which are mainly in the form of glycosides, 
than the free phenolics which are mainly in the form 
of aglycones. Since the enzymes (α-amylase and ACE) 
are active in the aqueous phase, direct enzyme-inhibitor 
interaction is expected to be higher with bound pheno-
lics compared with the free ones. A previous work with 
herbal extracts suggested the inhibitory activity of phe-
nolics may involve the disulfide bridges situated on the 
external surface of α-amylase, thus modifying enzyme 
structure and function (47). Therefore, the inhibition of 
α-amylase and ACE by V. persica bound phenolic ex-
tract could be due to the direct interaction of the pheno-
lics with the disulfide bridges of the enzymes.
Total phenol content of V. persica extracts is pre-
sented in Table 2. The results revealed that free phe-
nolic content (78.45 mg/100 g) was significantly (P < 
0.05) higher than the bound phenolic (54.77 mg/100 g) 
content. Our data on V. persica are in agreement with 
previously published articles on different plants (24, 39, 
43-45, 48).
The total antioxidant capacity measured as trolox 
equivalent antioxidant capacity (TEAC) is reported in 
Table 2. Free phenolic extract exhibited significantly 
(P < 0.05) higher antioxidant capacity than the bound 
phenolic extract, showing the same trend observed for 
the total phenol content (Table 2) and suggesting that 
antioxidant properties of plant products are correlated 
with their phenol content (24, 49). Polyphenols are 
powerful plant antioxidants, which play a pivotal role 
in adsorbing and neutralizing free radicals, quenching 
singlet and triplet oxygen, or breaking up peroxides 
(50). Phenolics are almost ubiquitous in plant orga-
nisms, where they can be found in different tissues as 
free aglycones and in conjugated (bound) forms either 
with sugars (primarily glucose) as glycosides or other 
moieties (51). Generally, conjugation occurs via the 
hydroxyl groups present in the phenolic backbone, 
consequently decreasing their antioxidant capacity, 
since the availability of free hydroxyl groups on the 
phenolic rings is essential for resonance stabilization of 
free radicals. Evidence about the antioxidant activity of 
Veronica species is scanty, although few studies support 
that certain Veronica species reveal antioxidant activity 
(52, 53). Persicoside, a phenylethanoid glycoside, was 
identified from the aerial parts of V. persica (54), while 
many phenylethanoid glycosides were found to have a 
broad range of biological activities, including antioxi-
dant and anticancer properties (55-58). Nonetheless, 
the suppressive effect of Veronica species on NO pro-
duction may arise from the presence of a high content 
of phenolic compounds such as flavonoids and pheny-
lethanoids (59). Different phenolic compounds from Ve­
ronica species have been investigated (53, 60, 61), most 
of them beneficial for human health. The consumption 
of phenolic compounds is also useful for lowering or 
delaying the development of inflammation as result of 
their antioxidant activity (62). Along this direction, we 
also found the V. persica phenolic extracts showed redu-
cing power, demonstrated as ascorbic acid equivalent 
(Table 2), revealing the free phenolic extract had higher 
reducing power than the bound phenolic extract. Redu-
cing power is a strong antioxidant mechanism involving 
electron and hydrogen atom transfer (63, 64), and these 
results are consistent with the total phenol content of 
the extracts. 
Conclusions
V. persica phenolic-rich extracts showed the poten-
tial to inhibit in vitro α-amylase, α-glucosidase and ACE 
activities and, therefore, this plant could be a valuable 
dietary supplement for managing postprandial hyper-
glycemia and hypertension associated to type 2 dia-
Figure 3. ACE (angiotensin I converting enzyme) inhibitory acti-
vities of Veronica persica phenolic-rich extracts. Data represent 
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betes, and as well as a promising antioxidant agent. 
Nevertheless, the enzyme inhibitory activities (except 
for α-glucosidase) were not associated with the pheno-
lic content of the V. persica extracts, rather being pos-
sibly related with type and properties of the phenolic 
compounds. The potential pato-physiological relevance 
of these findings requires to be further investigated in 
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